The End of Alzheimer’s

Dr. Lewis is an inorganic and physical chemist with degrees from Worcester Polytechnic Institute (WPI) and the Massachusetts Institute of Technology (MIT). In addition to a Ph.D., Dr. Lewis has training from the Harvard School of Public Health in Toxicology, Industrial Hygiene, and a certificate in Industrial Hygiene from the University of Massachusetts. Fundamentally Dr. Lewis is a medical researcher and medical information translator. Much of his knowledge comes for the clinical work of Dr. Clement L. Trempe and Dr. Kilmer McCully. These clinicians are pioneers in systemic chronic diseases, disease detection using ocular biomarkers, germ theory, inflammatory diseases, and micronutrient balance in immune health. He is the founder of the RealHealth companies including RealHealth Clinics. Dr. Lewis is also engaged in developing new small molecule therapeutics for the treatment of diseases of aging, with special focus on Alzheimer’s disease. Dr. Lewis holds patents (pending) on novel approaches to treat cancer and methods and approaches for treating chronic diseases of aging, including Alzheimer’s disease and macular degeneration. In addition, he has patents pending on a new risk calculator for chronic disease which he has trademarked "chronic disease temperature(tm)." Dr. Trempe received his MD degree from Ottawa Medical School, Canada. He furthered his studies at Harvard’s Schepens Eye Research Institute (SERI) and Massachusetts Eye and Ear Infirmary, Boston. He has been on staff at Harvard Medical School teaching hospitals since the 1970s. Dr. Trempe didn’t set out to solve the Alzheimer’s conundrum, he instead set out to treat eye diseases in a different way: treat the causes of the sick body and the health of the eye will also improve. When Dr. Trempe started diagnosing and treating his “eye” patients for systemic diseases, their eyes got better and stayed much better compared to people who were treated as if their eyes existed in isolation from the rest of the body. This multidisciplinary approach resulted in many patients with serious disease beyond the eye reporting that their other conditions improved upon Dr. Trempe’s “eye” (whole body) treatments. One of those conditions that improved was Alzheimer’s disease. His medical career at Harvard Medical School has spanned five decades. He is the author of hundreds of medical/scientific papers, two pending patents, and two books.

1. Is it Alzheimer’s?2. The Amyloid Cascade Hypothesis3. Diagnosis of Alzheimer’s4. Molecular Causes and Research5. Can Medicine Save You?6. A New Diagnostic Paradigm – The Molecular Eye7. Inflammation – Friend or Foe?8. Alzheimer’s Beyond the Brain – Molecular Research in the Body9. Does Infection Cause Alzheimer’s?10. Alzheimer’s Disease Prevention 11. Differential Diagnosis toward a Cure for Alzheimer’s

Appendix1: Signs, symptoms, and stages of Alzheimer’s2: Alzheimer’s Research at the Cellular Level3: Concept of a Medical "Cure"4: Alzheimer’s Disease Statistics5: Eye and Whole Body Diseases